Browsing by Author "Mohamed, Mouhand F H"

Now showing items 1-16 of 16

    • Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 

      Stein Emil, Vollset; Ababneh, Hazim S; Abate, Yohannes Habtegiorgis; Abbafati, Cristiana; Abbasgholizadeh, Rouzbeh; ... more authors ( Elsevier , 2024 , Article)
      BackgroundFuture trends in disease burden and drivers of health are of great interest to policy makers and the public at large. This information can be used for policy and long-term health investment, planning, and ...

    • Colchicine use might be associated with lower mortality in COVID-19 patients: A meta-analysis 

      Elshafei, Mohamed Nabil; El-Bardissy, Ahmed; Khalil, Ahmed; Danjuma, Mohammed; Mubasher, Mahmood; ... more authors ( Wiley-Blackwell , 2021 , Article)
      Background: Colchicine was recently repurposed for the management of coronavirus disease 2019 (COVID-19). This rapid review and meta-analysis aimed to assess colchicine's impact on mortality outcomes in COVID-19 patients. ...

    • Comparative effectiveness and safety of direct oral anticoagulants compared to warfarin in morbidly obese patients with acute venous thromboembolism: systematic review and a meta-analysis 

      Elshafei, Mohamed Nabil; Mohamed, Mouhand F.H.; El-Bardissy, Ahmed; Ahmed, Mohamed Badie; Abdallah, Ibtihal; ... more authors ( Springer , 2021 , Article)
      Direct oral anticoagulant (DOAC) agents are becoming the anticoagulation strategy of choice. However, their use in the treatment of acute venous thromboembolism (VTE) in morbidly obese patients (bodyweight of > 120 kg or ...

    • Comparative effectiveness and safety of direct-acting oral anticoagulants (DOACS) for the reduction of recurrent venous thromboembolism in cancer patients: A protocol for systematic review and network meta-analysis using a generalized pairwise modeling methodology. 

      Danjuma, Mohammed Ibn-Mas'ud; Mohamed, Mouhand F H; ElShafei, Mohamad Nabil; Fatima, Haajra; Shokri, Shaikha Al; ... more authors ( Lippincott, Williams & Wilkins , 2020 , Article)
      There has been a significant improvement in both our understanding and therapeutic choices available to clinicians for the management of cancer associated thrombosis (CAT). Even with the recent publication of a systematic ...

    • Direct oral anticoagulants are effective and safe in the treatment of venous thromboembolism and atrial fibrillation in morbidly obese patients 

      Mohamed, Mouhand F.H.; Elewa, Hazem; Mubasher, Mahmood; Danjuma, Mohammed ( Springer , 2020 , Other)
      There has always been unresolved uncertainty regarding the therapeutic utility of direct oral anticoagulants (DOACs) in morbidly obese patients (BMI > 40 kg/m2 or weight > 120 kg) with clinical indications for anticoagulant's ...

    • The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis 

      Khalil, Ahmed; El-Bardissy, Ahmed; Danjuma, Mohammed; Ahmed, Mohamed Badie; Mohamed, Mouhand F.H.; ... more authors ( Lippincott, Williams & Wilkins , 2020 , Article)
      BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-COV2) infection is a recently emerged viral infection causing predominantly mild upper respiratory symptoms. However, in some instances, it might result in ...

    • Global Burden of Cardiovascular Diseases and Risks, 1990-2022 

      George A., Mensah; Fuster, Valentin; Murray, Christopher J.L.; Roth, Gregory A.; Mensah, George A.; ... more authors ( Elsevier , 2023 , Other)
      The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) is a multinational collaborative research study with >10,000 collaborators around the world. GBD generates a time series of summary measures of health, ...

    • Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 

      Alize J, Ferrari; Santomauro, Damian Francesco; Aali, Amirali; Abate, Yohannes Habtegiorgis; Abbafati, Cristiana; ... more authors ( Elsevier , 2024 , Article)
      BackgroundDetailed, comprehensive, and timely reporting on population health by underlying causes of disability and premature death is crucial to understanding and responding to complex patterns of disease and injury burden ...

    • The impact of enteric coating of aspirin on aspirin responsiveness in patients with suspected or newly diagnosed ischemic stroke: prospective cohort study: results from the (ECASIS) study 

      Elshafei, Mohamed Nabil; Imam, Yahia; Alsaud, Arwa Ebrahim; Chandra, Prem; Parray, Aijaz; ... more authors ( Springer Nature , 2022 , Article)
      Background and purpose: Uncertainty remains regarding the impact of enteric-coated aspirin (EC-ASA) on secondary prevention of ischemic stroke compared to plain aspirin (P-ASA). Hence, this study was designed to investigate ...

    • An Investigation into the Association Between Inflammatory Bowel Disease and Cardiac Arrhythmias: An Examination of the United States National Inpatient Sample Database 

      Mubasher, Mahmood; Syed, Tausif; Hanafi, Amir; Yu, Zhao; Yusuf, Ibrahim; ... more authors ( SAGE Publications , 2020 , Article)
      Background: Inflammatory bowel diseases (IBD) associated-chronic inflammation and autonomic dysregulation may predispose to arrhythmias. However, its exact prevalence is unknown. Thus, we aimed to ascertain the prevalence ...

    • An investigation into the impact of enteric coated of aspirin in patients with newly diagnosed ischemic stroke (ECASIS) 

      Elshafei, Mohamed Nabil; Imam, Yahia; Mohamed, Mouhand F.H.; Alsaud, Arwa Ebrahim; Ahmed, Mohamed Sayed; ... more authors ( Wolters Kluwer Health , 2020 , Article)
      Introduction:Uncertainty remains regarding the impact of enteric-coated (EC) aspirin as it relates to the reduction of cardiovascular risk. We hypothesize that EC formulation based on a previous report may blunt aspirin ...

    • Myxedema psychosis: A protocol for a systematic review and a pooled analysis 

      Mohamed, Mouhand F.H.; Siepmann, Timo; Suwileh, Salah; Mohammed, Mohammed H.; Mohamed, Samreen; ... more authors ( Wolters Kluwer Health , 2020 , Article)
      Background: Myxedema psychosis (MP) is a rare presentation of hypothyroidism. Although known for >70 years, a significant lack of systematic literature describing this condition exists. This limits the clinician's ability ...

    • Myxedema psychosis: Systematic review and pooled analysis 

      Mohamed, Mouhand F.H.; Danjuma, Mohammed; Mohammed, Mohammed; Mohamed, Samreen; Siepmann, Martin; ... more authors ( Dove Medical Press , 2021 , Article)
      Background and Objective: The term myxedema psychosis (MP) was introduced to describe the occurrence of psychotic symptoms in patients with untreated hypothyroidism, but the optimal assessment and treatment of this condition ...

    • The Net Clinical Benefit of Rivaroxaban Compared to Low-Molecular-Weight Heparin in the Treatment of Cancer-Associated Thrombosis: Systematic Review and Meta-Analysis 

      Mohamed, Mouhand F.H.; ElShafei, Mohamad Nabil; Ahmed, Mohamed Badie; Abdalla, Lina O.; Ahmed, Israa; ... more authors ( SAGE , 2021 , Article)
      Cancer-associated thrombosis (CAT) carries significant morbidity and mortality. Low-molecular-weight heparin (LMWH) remains the standard of care, with recent systematic studies suggesting the efficacy and safety of rivaroxaban ...

    • Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis 

      Mohamed, Mouhand F.H.; Al-Shokri, Shaikha D.; Shunnar, Khaled M.; Mohamed, Sara F.; Najim, Mostafa S.; ... more authors ( Frontiers Media S.A. , 2021 , Article)
      Background: Recent studies revealed a high prevalence of venous thromboembolism (VTE) events in coronavirus disease 2019 (COVID-19) patients, especially in those who are critically ill. Available studies report varying ...

    • QTc evaluation in COVID-19 patients treated with chloroquine/hydroxychloroquine: A letter to the editor 

      Danjuma, Mohammed I.; Sinha, Urshita; Fatima, Haajra; Mohamed, Mouhand F.H.; Nathoe, Hendrik ( Wiley-Blackwell , 2020 , Other)
      We read with interest Monzani et al's report1 on QT pro-longation in COVID-19 patients on treatment with chloro-quine/hydroxychloroquine (CQ/HCQ). Her report highlights the therapeutic morbidities ...